MedCity News
JUNE 16, 2023
Similarly, a 2019 study found rural residents had a five-year relative cancer survival that was 5.2% Trial access equity and inclusivity are important considerations for sponsors given the results of a 2021 analysis of U.S. lower than metropolitan or urban residents and a 10% increase in risk of death after adjustment for multiple factors.
European Pharmaceutical Review
FEBRUARY 27, 2024
Previous roles The MHRA highlighted Dame June Raine has been Chief Executive Officer of the MHRA since August 2019. Her educational background includes training in medicine in Oxford after completing a master’s degree by research in Pharmacology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 23, 2022
The researchers studied 254 VA patients who were diagnosed with PTSD and hepatitis C between October 1999 and September 2019. Many people have PTSD, but there [are] few effective pharmacologic treatments and limited drug development for PTSD,” commented Gradus. The findings are to be published in the American Journal of Epidemiology.
European Pharmaceutical Review
MAY 2, 2023
In 2019, the pharmaceutical industry spent $83 billion on R&D, which is about 10 times what the industry spent per year in the 1980s, 4 yet the average duration to develop a new medicine is still around 10-15 years. About the authors Dr Nils Eckardt joined BeiGene in February 2019 as Vice President, Medical Affairs, Europe.
European Pharmaceutical Review
DECEMBER 11, 2023
Known linkers in the RNA field are used to bond together the two pharmacologically active molecular entities and can be applied to multiple oligonucleotide modalities. 2019 ;42:385-406. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. Internet] Nature Portfolio. Antiviral agents.
Pharmaceutical Technology
FEBRUARY 8, 2023
Xu gave the example of the FDA’s first approval of an AAV-based gene therapy for paediatric spinal muscular atrophy patients in 2019, saying that evidence of effectiveness generated from two single-arm externally controlled clinical trials in patients with infantile onset SMA was substantial enough for an approval.
Pharmaceutical Technology
DECEMBER 16, 2022
This year saw great progress towards making new therapeutics for malaria available sooner rather than later, says Karen Barnes, PhD, professor at the University of Cape Town’s Division of Clinical Pharmacology. As per the WHO’s 2022 malaria report , 63,000 malaria deaths were attributed to Covid-19-caused disruptions to services from 2019–21.
Expert insights. Personalized for you.
311 
Let's personalize your content